Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The objectives are 1. to determine the immunological profile (CD4+, CD8+ cells, DTH) induced by immunization with HCV antigen peptide vaccine with polyarginine. 2. to document virological (HCV-RNA) and biochemical (ALT) responses following immunization with HCV antigen peptide vaccine with polyarginine. 3. to assess the safety of immunization with HCV antigen peptide vaccine with polyarginine.
Epistemonikos ID: 4723c6037d9bb06c61d506ebf8113b5851adc627
First added on: Mar 23, 2020